People | January 07, 2022
Barentz appoints Daniel Hitz as CEO, APAC
Hitz shall assume new role from January 17th, 2022
Hitz shall assume new role from January 17th, 2022
He has over 22 years of experience in pharmaceutical sales & business development
Investment in single-use endoscopes, digital solutions, and endoluminal therapies expected
As part of the out-licensing deal with Tabuk, Biocon will develop and manufacture the products, and Tabuk will commercialise them
It works with Pfizer to support more rapid innovation and improved clinical manufacturing operations to help develop tomorrow’s therapies
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021
The new products include the COAG Line automated, semi-automated and POC systems manufactured by Diagon Hungary
It is one of the first companies to launch a bioequivalent version of the dry powder inhaler and it's part of the company’s strategic exclusive in-licensing arrangement to market Tiotropium DPI in Western Europe and the UK
FUJIFILM will distribute iSWAB bio sampling technologies in Japan
Subscribe To Our Newsletter & Stay Updated
